{"id":14456,"date":"2021-07-22T08:08:32","date_gmt":"2021-07-22T08:08:32","guid":{"rendered":"https:\/\/interhospi.com\/?p=14456"},"modified":"2021-07-22T08:08:32","modified_gmt":"2021-07-22T08:08:32","slug":"fda-clears-dexcom-real-time-diabetes-monitoring-apis-for-third-party-apps-and-devices","status":"publish","type":"post","link":"https:\/\/interhospi.com\/fda-clears-dexcom-real-time-diabetes-monitoring-apis-for-third-party-apps-and-devices\/","title":{"rendered":"FDA clears Dexcom real-time diabetes monitoring APIs for third-party Apps and devices"},"content":{"rendered":"

\"dexcom\"<\/p>\n

DexCom, a global leader in real-time continuous glucose monitoring for people with diabetes, has received US FDA clearance of the Dexcom Partner Web APIs, enabling invited third-party developers to integrate real-time CGM data into their digital health apps and devices.<\/p>\n

\u201cThe new APIs will help seamlessly integrate the power of real-time Dexcom CGM data into some of the leading diabetes and digital health solutions,\u201d explained Jake Leach, chief technology officer at Dexcom<\/p>\n

\u201cFDA clearance of our real-time APIs further solidifies Dexcom as the leader in interoperable CGM, giving Dexcom users even more choice in how they view and interact with their glucose data,\u201d said Leach.<\/p>\n

People with diabetes and their healthcare providers will benefit from the integration of real-time Dexcom CGM data into third-party apps and devices in a multitude of ways. For example, it will:<\/p>\n